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Abstract
Experimental evidence is increasingly being used to reassess the quality and accuracy of genome annotation. Proteomics
data used for this purpose, called proteogenomics, can alleviate many of the problematic areas of genome annotation, e.g.
short protein validation and start site assignment. We performed a proteogenomic analysis of 46 genomes spanning eight
bacterial and archaeal phyla across the tree of life. These diverse datasets facilitated the development of a robust approach
for proteogenomics that is functional across genomes varying in %GC, gene content, proteomic sampling depth,
phylogeny, and genome size. In addition to finding evidence for 682 novel proteins, 1336 new start sites, and numerous
dubious genes, we discovered sites of post-translational maturation in the form of proteolytic cleavage of 1175 signal
peptides. The number of novel proteins per genome is highly variable (median 7, mean 15, stdev 20). Moreover, comparison
of novel genes with the current genes did not reveal any consistent abnormalities. Thus, we conclude that proteogenomics
fulfills a yet to be understood deficiency in gene prediction. With the adoption of new sequencing technologies which have
higher error rates than Sanger-based methods and the advances in proteomics, proteogenomics may become even more
important in the future.
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Introduction
With the advance in sensitivity and computational power of
high throughput proteomics, many datasets now offer expansive
proteome coverage. A growing trend is to use these data to re-
evaluate protein sequence predictions, i.e. proteogenomics [1,2].
As most genome annotation pipelines consist of automated gene
finding, they lack experimental validation of primary structure
[3,4]. Thus proteogenomics offers valuable opportunity to correct,
corroborate, and supplement genomic predictions as an orthog-
onal data-type from DNA-centric evidences (e.g., sequence
homology, transcriptome mapping, codon frequency, etc.). In a
variety of organisms, new insight from proteogenomics has
consistently improved genome annotation [5,6,7,8,9].
Fundamentally, an accurate primary structure implies knowing
the correct start/stop coordinates of the protein, which may be
erroneously predicted for 20% of genes in some bacterial and
archaeal genomes [10,11], as well as recognizing any true frame-
shifting events, that should be distinguished from sequencing
errors. A more advanced gene model should contain information
about the mature protein sequence. For example, protein cleavage
events such as N-terminal signal peptides are particularly valuable
clues for protein localization in the prokaryotic cell. Similarly,
characterizing a mature antimicrobial from the nascent pre-
protein can add valuable information as to how such a protein
assumes its biological role [12]. Furthermore, modifications to
amino acids (e.g., phosphorylation) can implicate a protein in
distinct and often transient biological processes (e.g., regulation of
gene expression). None of these protein maturation events are
observable via DNA sequencing.
Proteogenomics as a field has tended to utilize datasets
generated from a single organism or biological system. Although
various techniques have been explored to gain more proteome
coverage [13] or to recover specific subsets [14] or target protein
N-termini [15], little work to re-evaluate protein annotation has
been performed with datasets from multiple organisms. Gupta et
al. first explored the concept of comparative proteogenomics with
the analysis of three different Shewanella [16]. A major finding of
this work was that the confidence of ‘one-hit-wonder’ proteins
could be increased by the observation of orthologs in a different
species’ proteomics dataset.
We have previously published a proteogenomics methodology
for discovering novel protein coding regions using only a single
organism, Yersinia pestis [17]. To ensure the generality of our
approach, we tested it on 46 organisms from eight bacterial and
archaeal phyla. This expansive diversity uncovered shortcomings
and flaws observable only in certain datasets, and produced a
more robust pipeline. Selected results are highlighted to describe
the types of events that can be discovered, including new genes,
conflicts with current genes, disputation of pseudogenes, and
mature protein events. In total we reveal over 2000 new and
corrected genes. We also looked for reasons why novel genes
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27587identified in this study may have been missed in the original
genome annotations.
Results
Proteogenomic analyses are defined by a search for novel
protein coding regions in an organism’s genome. To accomplish
this, proteomic data is searched to identify sequences which are
not currently part of the genome annotation. Tandem mass
spectra are typically interpreted using a protein sequence database
to facilitate peptide identification [18]. In our proteogenomic
pipeline [17], peptide/spectrum matches (PSMs) are identified
from a six frame translation of the genome, instead of simply the
predicted protein sequences. Only highly confident identifications
are kept; the default cutoff for our pipeline is an MSGF score of
1e-10 [19]. Peptide sequences are mapped to their genomic locus
and grouped with other peptides within an open reading frame
(ORF). Many proteogenomics methodologies do not perform any
additional filtering and simply assert novel coding regions from all
novel peptides. After testing our pipeline on numerous datasets, we
have found that this is insufficient. We adapted our existing
proteogenomics pipeline [17] to be functional across genomes
varying in %GC, gene content, phylogeny, and genome size.
Additionally, our pipeline has been tested on datasets with over 15
million tandem mass spectra and those with only ,100,000,
showing robustness regardless of proteomic sampling depth. Using
46 organisms (Table S1) with a wide variety of characteristics, we
refined the data processing path, most notably FDR stringency
and ORF filtering (see Methods for a full description).
Pipeline Updates
As a first step towards improving the proteogenomics pipeline,
we replaced the local false-discovery rate (lFDR) with the exact p-
value of a PSM. An lFDR is a heuristic approximation of a pvalue,
which bins PSMs by score and calculates the false-discovery of
each bin [20]. This method is not robust for small or medium
datasets where too few results of a given score range force the bin
size larger, removing most of the intended discriminating power.
Moreover, the pvalue as calculated by the scoring algorithm
MSGF is PSM specific, and not a grouped approximation [19].
Finally, we have dramatically decreased the permissible FDR; the
current default cutoff for MSGF is 1e-10 which typically results in
a spectrum level FDR of 0.01% (peptide FDR,0.3%).
Even at high PSM specificity (spectrum FDR,,0.01%), some
of the proteogenomic predictions such as novel genes could be
wrong. The need for filters which operate on open reading frames
(not simply PSMs) was identified from the observation of multiple
suspect coding regions at zero false-discovery. False-discovery of
0.0% was achieved by increasing MSGF stringency to 1e-13 or 1e-
14 instead of 1e-10. In these tests zero spectra were identified with
peptides from the decoy database. Therefore, all novel peptides
were inspected as potentially confirming novel genes, not requiring
two peptides per ORF. In multiple organisms, we observed
proposed novel coding regions that completely overlapped
currently annotated proteins with substantial peptide support
(Figure S1). Additionally many of these ORFs lacked a start codon.
Such ORFs were always represented by one peptide. As a result of
these suspect coding regions which are present even at a presumed
zero false-discovery, we found it necessary to utilize ORF filters
(see Methods). ORF filters are not meant to overcome loose PSM
filters, but rather to help identify putative coding regions that are
likely false-positive even when all PSMs are highly confident. We
previously used four ORF filters [17], however in the analysis of
genomes with high GC, it was necessary to add a peptide length
clustering filter. High GC genomes have many long open reading
frames that are not genic. These long ORFs have a potential to
contain multiple false-positive peptides, which would pass the two
peptide filter. After modeling the interpeptide distance from all
known proteins with proteomic data, we set a maximum
interpeptide distance at 750 nucleotides. Using this length filter,
we were able to remove many false-positive protein predictions in
high GC genomes.
Conflict Resolution
We further discriminate potential novel coding regions by
characterizing their location relative to other genes. Of the over
2000 novel coding events we discovered, most are located in
empty regions of the genome lacking any annotation. Regardless
of whether the genes have strong homology to known proteins
(Figure 1A and B), they can still be confidently added to a
genome’s annotation. However, complications can arise when
proposed novel coding regions overlap current genomic features.
As bacterial genomes have a very high coding density, new coding
regions occasionally overlap with current annotations (e.g. utilizing
a different frame of translation). Therefore, we created a ‘‘conflict
report’’ to judge the accuracy and specificity of proposed
proteogenomic corrections. Overlapping proteins were split into
six categories, each with an a priori interpretation of biological
feasibility (see Methods). Levels 1 and 2 consisted of protein
overlaps under 40 bp, a common event in bacterial genomes
[21,22], and were not considered conflicts.
Conflict levels 3–6, which consisted of overlaps in excess of
40 bp, required more careful inspection. Conflict levels 3 and 4
had proteomic support (i.e. peptides) for only one of the genes
involved in the overlap, and are differentiated by the unsupported
protein. In a level 3 conflict, the non-observed protein is
hypothetical (Figure 1C), and almost all level 3 conflicts arise
from dubious annotation. Commonly, the genomic DNA at these
loci contains multiple competing open reading frames, and the
gene prediction algorithm failed to choose the correct frame.
Although the number and type of conflicts were widely variable
between datasets, level 3 conflicts were generally more common
than levels 4, 5, or 6 (Table S2). A level 4 conflict occurred when
the unobserved protein was named anything but ‘hypothetical’.
Before stringent PSM and ORF filters, we encountered many level
4 conflicts. Based on our observations, a large number of level 4
conflicts were generally indicative of high protein FDR. Conflict
levels 5 and 6 occurred when both overlapping proteins had
proteomic support (see Methods). Again, most often these conflicts
were signs of high protein FDR. Although two proteins rarely
overlap by more than 40 nucleotides in bacteria [23], we have
observed a few in high GC organisms.
The decline in conflict levels 4,5,6 as PSM stringency increases
closely mirrors the decline in novel genes predicted. For example,
in Caulobacter changing the MSGF cutoff from 5e-08 to 1e-10
changes the PSM FDR from 0.5% to 0.02% (peptide FDR 5%
and 0.3% respectively). Coordinated with this increased stringency
is a decrease in novel genes (195 to 25) and conflicts levels 4, 5, 6
(261 to 49). Moreover, at the stringent level, almost all remaining
conflicts (45/49) are between current genes, not involving
proposed novel genes. As a comparison, the number of protein
identifications for current annotations decreases only marginally
over this range, 2725 identifications to 2551. The decrease in
conflicts (levels 4, 5, 6) coordinated with PSM stringency is a
general principle (Table S3). On average when going from MSGF
cutoff of 5e-08 to our default f 1e-10, the number of conflicts
decreases 4 fold (mean 4.0, median 2.2). The number of novel
proteins is also over inflated with less stringent FDR (mean 3.46
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First loose FDR leads to numerous false-positive predictions.
Second, conflict classification as presented here shows good
specificity in highlighting likely false-positives.
Genome Annotation Deficiencies
In an effort to discover why novel genes identified in this study
were missed during the original genome annotation we first looked
at whether the omission is strictly a function of older annotation,
i.e. have gene prediction algorithms solved the problem already?
There was no correlation between the number of annotation
corrections and date of the genome annotation or genome GC
levels: correlation coefficient of 20.38 and 0.15 respectively
(Figure S2, S3). Looking gene by gene at characteristics like %GC
and codon usage, we did not find novel genes distinct or outside of
the norm (Figure S4, S5). Although many of the novel genes were
short, they were not below the cutoff for annotation (Figure S6).
We also looked at genome context for novel genes: those that
overlapped an annotated gene, those that overlapped a pseudo-
gene, and those that did not overlap any genomic feature. The
relative proportion of these three groups varied widely by genome.
For example, in Caulobacter almost all novel genes overlapped an
annotated gene (level 3 conflict); however, in Synechocystis, all genes
were simple novel genes, and did not overlap any genomic feature.
In many of the genomes, peptides overlap a genomic region
demarcated as a pseudogene. We observed at least three categories
of pseudogene misannotation (Figure 2). In the first type of
misannotation, peptides were identified in a single open reading
frame spanning the entire start-stop of the predicted pseudogene
(Figure 2A). As the peptides within this span make a coherent gene
model without frameshifts or interruptions, it was unclear why
these were annotated as a pseudogene. Figure 2B shows the murF
locus of Geobacter sulfurreducens; peptides lie in two different frames
of translation. Thus according to the straightforward interpreta-
tion of the genome, this cannot make a single protein. One
possible explanation is that there is a DNA sequence error (indel)
causing the apparent frame shift; a separate possibility is that there
are two protein products at this locus, although there are no other
examples of this gene being split. The third pseudogene
misannotation shows the true conceptual translation of a
pseudogene, where the reading frame ends before the gene model,
Figure 2C. Thus the translation could be described as a partial
gene product. The original Genbank annotation notes that the
open reading frame is a partial hit to Pfam PF02518, a histidine
kinase-like ATPase, but other protein family profiles support this
sequence as containing the full domain (e.g. cd00075 from NCBI’s
CDD).
In vivo cleavage - Signal peptides and lipoproteins
Many subcellular localization mechanisms utilize conserved
sequence motifs that serve as molecular addresses and often
involve enzymatic cleavage in proximity of the motif. This
cleavage creates a new protein N-terminus that is amenable to
discovery via proteomics.
Figure 1. Novel coding content. Regions of a genome are shown where novel peptides (grey arrows) are not contained within a currently
annotated protein. A, an unannotated region of Geobacter sulfurreducens corresponding to ribosomal protein S12. B, an unannotated region of
Rhodobacter sphaeroides plasmid for which there are no blast matches. C, a level 3 conflict in Caulobacter crescentus. Currently annotated protein
CCNA_003785 (white arrow) is dubious and should be replaced with a gene model on the opposite strand.
doi:10.1371/journal.pone.0027587.g001
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dependant pathway contain a ,20 residue N-terminal sequence
to target the protein to the membrane and mediate cleavage. The
signal peptide contains three conserved motifs: early basic
residue(s), a hydrophobic patch, and a three residue recognition
motif for signal peptidase I [24]. We identify sites of signal peptide
cleavage in proteomics data by finding the first peptide of a protein
as non-tryptic on its N-terminus, and then requiring the three
conserved motifs. Requiring these three elements filters the
proposed signal peptide set by 20–80% as compared to previous
methods [9], greatly increasing specificity. We identified 1175 sites
of signal peptide cleavage. By aligning the three residues prior to
cleavage (23, 22, 21) with the two following cleavage (+1, +2),
we determined the observed signal peptidase I recognition motif
by taxa (Figure 3). In general, the motif is similar between taxa and
alanine is expectedly prominent at residues 21 and 23. Previous
reports of bacterial signal peptides have uniformly reported the
‘AxA’ motif for signal peptidase I cleavage [25,26].
We observed additional maturation signals in proteins that
contained a non-tryptic first peptide, but failed to contain at least
one of the three signal peptide criteria. In Arthrobacter, many
proteins lacked the signal peptidase I recognition motif, but instead
contained the common sequence L-x-G/A-C, the lipoprotein
signature. A final type of N-terminal maturation was N-terminal
methionine excision, or NME. An exceptionally large fraction of
proteins lacking a hydrophobic patch had methionine immediately
prior to the first peptide (e.g., 45% for Caulobacter and 55% for
Cyanothece). In most of these instances the first peptide started with
alanine or other residues consistent with NME [27], suggesting
that the protein is predicted too long.
Discussion
Although intense effort has gone into determining the correct
functional annotation of proteins [28], primary gene structures are
still imperfect. Proteomics provides a powerful experimental data
type to access and improve the quality of genome annotation. A
key advantage is the direct correlation between protein annotation
and a protein based assay. In this study, analysis of 46 genomes
spanning eight bacterial and archaeal phyla across the tree of life
allowed us to develop a robust approach for proteogenomics
annotation that is functional across genomes varying in %GC,
gene content, proteomic sampling depth, phylogeny, and genome
size. In proteogenomics, specificity proves more important than
sensitivity and leniency at the hopes of greater genome coverage
can dramatically increase the chance for false-positive novel
protein identification. We evaluate the quality of proposed
proteogenomic corrections through the conflict report. By no
means implying that overlapping proteins are not real or cannot
be found by proteogenomics [29], the vast majority of novel
proteins with significant overlap were typically low quality and
weeded out by stringent filters.
Our effort to understand why genes are missed in the initial
annotation revealed that the only consistent problem was the
expected sensitivity/specificity decline for short proteins. Citing
the diversity of other errors, we suggest that all genome
annotations leverage proteomics, either through concurrent
Figure 2. Classes of translated pseudogenes. Peptides (light grey arrows) are shown to map within pseudogene boundaries (dary grey arrows),
proving that the region is translated to protein. A, peptides in a single coherent open reading frame spanning the entire length of the pseudogene
LIC 12015 from Leptospira interrogans. It is unclear why such regions were designated as pseudogenes. B, peptides fall within two different translation
frames which are located within Geobacter sulfurreducens pseudogene GSU3073. This situation can arise when the underlying genome sequence is
erroneous and contains artificial indels, or if the two regions are separately translated. C, peptides fall in a single open reading frame which only
partially covers the genomic regions annotated as a pseudogene, Desulfovibrio vulgaris pseudogene DVU0699. This confirms the conceptual
translation of the pseudogene (i.e. ending in an in-frame non-sense codon).
doi:10.1371/journal.pone.0027587.g002
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proteomically verified ORFs as a part of their extrinsic evidence
set (i.e. in addition to blast or hmm searches).
For pseudogenes, we showed three types of misannotation, each
resulting from a different deficiency in the sequencing and
annotation process. Resolving the annotation of these is difficult,
partially attributable to the potential for genome sequence errors.
More pointedly, there is not a consensus on the meaning of
‘pseudogene’, whether ‘non-functional’ applies to the translated
product’s biochemical function or to the ability of a genomic locus
to produce a viable transcript which gets translated. While this
discussion is outside of the scope of this work, our perspective as
proteomic scientists is that all translated products should be
included in common database downloads.
We focused largely on false-negative annotations, where a
region of DNA was not assigned to be protein-coding, but should
have been. A more difficult misannotation is false-positives, which
we find as novel/dubious pairs in the data and are more apparent
for some genomes. These dubious genes can have far reaching
effects, as they propagate through future genome annotations in
what is known as ‘‘transitive disaster’’.
As a final part of our methodology, we analyze the datasets to
discover in vivo protein cleavage. Proteomic determination of
cleavage sites offers several distinct advantages over strictly
computational approaches that predict cleavage events directly
from sequence. In addition to providing experimental validation of
cleavage, proteomics yields a broad and unbiased sample of
cleaved proteins. For example, in the Geobacter data sets over 150
proteins were identified as having a signal peptide, yet the overlap
between these three genus members was only nine proteins. Thus
a large number of distinct proteins were identified. This diverse set
could serve as a powerful training/testing set to improve
computational tools.
Materials and Methods
The pieces of the data processing path are outlined below.
MS/MS data generation
All datasets were generated using Thermo LTQ mass spectrom-
eters. Vendor specific RAW formats were converted to mzXML
using the ReadW program (version 4.3.1). One dataset came from
PeptideAtlas: Streptococcus pyogenes (PAe000284-7). The Bacillus anthracis
data was published as part of the NIAID PRC and is available
at [ftp://141.161.76.88/pub/proteomics_ftp/michigan/uom_09/].
Yersinia pestis data have been previously described [17]. The rest of the
data were generated at PNNL; these data are available at
omics.pnl.gov. PNNL datasets were reported previously [30]. Almost
all were generated as part of a broad bottom-up proteomics
characterization of their respective organism. Global, soluble and
insoluble protein lysates were subjected to 2D LC-MS/MS.
MS/MS Interpretation
Mass spectra were searched by Inspect [31] against a translation
ofthegenomeand subsequently rescored with PepNovoand MSGF
[19]. Searches did not include any post-translational modifications,
but in accord with Inspect’s searching paradigm did not require
trypticspecificity.WedownloadedgenomicDNAfromRefSeq,and
translated all six frames to generate a protein database. Each stop to
stop open reading frame (ORF) was included regardless of coding
potential. We concatenated decoy records by shuffling each ORF.
We included a decoy database to help measure the relative peptide
FDR even though the final scoring algorithm (MSGF) does not use
the decoy hits to calculate itsprobability values. Significant peptide/
spectrum matches (PSM) were those with an evalue of e-10 or
better, which led to a peptide level FDR of ,0.3%. We note here
the distinction between PSM level FDR and peptide level FDR.
PSM level FDR is calculated from the collection of all spectra
passing filters and the number of those spectra with peptides
matching the decoy database. Peptide level FDR is calculated from
the list of peptide sequences passing filters (many of which were
identified in multiple spectra). Thisnumber is always larger than the
PSM FDR. For example, in the Mycobacterium tuberculosis dataset,
160,795 spectra passed the MSGF filter; 40 spectra identified
peptides from the decoy database. Thus the PSM or spectrum FDR
is 40/160,795 or 0.024%. Within these spectra, 23,451 peptides are
identified, of which 37 come from the decoy database. The Peptide
FDR is 0.1%.
Peptide spectrum matches from Inspect and MSGF, as well as
the mapped peptide locations for all datasets can be downloaded
from the PNNL website: http://omics.pnl.gov/pgp/overview.php.
ORF Filters
ORF filters are based on the set of peptides within an open
reading frame. All confident peptide identifications were mapped
Figure 3. Signal peptidase I motifs. The amino acid residues surrounding signal peptidase cleavage sites are shown for four organisms. The five
amino acid residues are three residues prior to cleavage (23, 22, 21) and two residues post cleavage (+1, +2). A, E. coli;B ,Caulobacter crescentus;
C, Deinococcus radiodurans;D ,Cyanobacterium synechocystis. Figures were created using weblogo.berkeley.edu with default parameters.
doi:10.1371/journal.pone.0027587.g003
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into sets within an ORF. We employ five ORF filters. First we
remove low complexity peptides, with .70% glycine and alanine
[17]. Next we remove peptides which are more than 750 bp from
the next in-frame peptide. We remove ORFs which lack a uniquely
mapping peptide or which lack a fully tryptic peptide. Finally, we
require two peptides per protein. The interpeptide length filter is
designed to overcome weakness in the min-peptide filter. The two
peptide rule relies on the lowprobability of two false-positives falling
within the same open reading frame. Yet for high GC genomes
there are numerous long open reading frames that are not genic.
Thus the likelihood of two peptides within one of these is higher. To
determine the average interpeptide distance we sorted all peptides
within a current protein annotation and then tallied the nucleotide
distance between consecutive pairs. We plotted a histogram of all
distances and found that 750 bp was an appropriate cutoff.
Conflict report
We created a conflict report to describe overlapping (i.e.,
conflicting) protein annotations. The types of conflict were
differentiated by the nucleotide length of the conflict and the
biological implication. We distinguished between annotated protein
region and proteomic evidence region. The annotated region was
obtained from the RefSeq record. The proteomic evidence region
was from the 59 most peptide through to the stop codon. Conflict
levels were defined as:
Level 1 –overlap by less than 10 bp.
Level 2 – overlap by less than 40 bp.
Level 3 – overlap by 40 bp or more. There is proteomic support
for only one protein; the unsupported protein contains ‘‘hypo-
thetical’’ in the name.
Level 4 – overlap by 40 bp or more. There is proteomic support
for only one protein; the unsupported protein does not contain
‘‘hypothetical’’ in the name.
Level 5 – overlap by 40 bp or more. There is proteomic support
for both proteins. The overlap is limited to the annotated region
and is not in the proteomic evidence region.x
Level 6 – overlap by 40 bp or more. There is proteomic support
for both proteins. The overlap is within the proteomic evidence
region.
Proteogenomic reannotation
Open reading frames passing filters were compared against the
RefSeq annotation. ORFs that contained peptides but not a
protein annotation were reported as novel proteins. ORFs that
have peptides upstream of a protein annotation are reported as
‘new start’ proteins. As a caveat for new start assignments, we
required that peptides contain at least two upstream amino acids
[17]. We also reported new starts when proteomic evidence was
indicative of an alternative start codon TTG or GTG translated as
Leucine or Valine. To determine the start site of proteogenomic
corrections (novel gene and new start), our overriding choice was
to find the upstream start site closest to the peptides found by mass
spectrometry, unless blast homology strongly suggested consensus
at another start site. We took a conservative approach; it is always
easier to add sequence (i.e. extend further upstream) than remove,
because of the difficulty of proving negative evidence. For peptides
that overlapped pseudogenes, we did not attempt to update
RefSeq with a new gene. Additionally, we did not attempt to
update a start sites when peptides had no upstream start site.
In Vivo Cleavage
To report a protein as containing a signal peptide, we started
with proteins where the first observed peptide was not tryptic on its
N-terminus, and was within 15–50 amino acids of the predicted
start site. Between the initial methionine and the first observed
peptide is the putative signal peptide. We filtered this set using
previously recognized signal peptide characteristics [24]. We
required a hydrophobic patch of at least eight contiguous amino
acids and examined the signal peptide terminus for the expected
cleavage motif. We also required a basic residue between the start
and the hydrophobic patch.
Lipoproteins were found in a similar manner, but with a distinct
motif L-x-G/A-C, where cysteine forms the first residue of the
mature protein and is modified with a lipid. In all instances,
however, the peptide identified in MS/MS began immediately
after the cysteine. As we did not search for any lipid modifications,
we did not expect to find any cysteine-modified peptides.
Observed peptides starting immediately after the cysteine were
considered evidence for a lipoprotein.
Supporting Information
Figure S1 False Positive Peptide at Zero FDR. The red
peptide (GGVGGHLAPDAAAR) is a fully tryptic peptide with an
MSGF e value of 7e-17. It lies in a small unannotated open
reading frame of 272 amino acids. This ORF has 100% overlap
with the current C. crescentus gene CCNA_00970, which is both a
well-known gene and also well supported by proteomics. This
proposed novel ORF is an example of a false-positive, which is
present even at presumed zero FDR.
(TIF)
Figure S2 Errors in annotation by year. Novel genes
discovered by proteogenomics are plotted by the year that the
original annotation was published. The high mark in the dataset
(y=113) is the Deinococcus genome, which suffers from significant
genome sequence errors (see errata in White et al 1999) likely
causing the exceptionally high misannotation rate. Discounting
that data point, errors seem to be uncorrelated with year.
(TIF)
Figure S3 Errors by GC. Novel genes discovered in
proteogenomics are plotted according to the GC content of the
genome. There appears to be no strong correlation between high
GC and error rate. As with figure S1, the high mark in the data set
(y=113) is believed to be an outlier due to abundant errors in the
genome sequence.
(TIF)
Figure S4 GC content by gene type. The GC distribution of
four gene categories. Grey is the genes for which proteogenomics
does not suggest a change. Blue is novel genes. Red is the novel
extension to a current gene. Green is the original (now c-terminal)
portion of genes that have been extended. In all datasets except the
Cyanobacterium, the unchanged and novel genes show similar GC
content. In Cyanobacterium, the novel genes appear to have lower
GC. The extensions to current genes (red) show a wider
distribution than their parent gene models (green).
(TIF)
Figure S5 Codon usage. Codon usage frequencies from all
unchanged genes have been dimension reduced to 2D through
principal component analysis (see Medigue et al., 1991). The
codon frequencies for novel genes were transformed using the
same pca vector weighting and mapped in blue on top of the
unchanged genes. Codon usage does not appear to be substan-
tively different between the novel and unchanged gene sets. A, C.
crescentus;B ,C. synechocystis;C ,D. desulfricans;D ,L. interrogans.
(TIF)
Proteogenomic Analysis of Bacteria and Archaea
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27587Figure S6 Length comparison. The length of all genes (grey)
has a median of ,900 nucleotides with a long tail out to 10,000
nucleotides. Novel genes (blue) are on average shorter than the
background distribution. However, they are not too short to have
fallen below cutoff.
(TIF)
Table S1 List of organisms presented in this study.
Along with each organism is listed the following information: the
percent GC of the genome, the date of genome submission to
genbank, the RefSeq accession of the primary chromosome, the
genome size in megabases, the number of novel genes discovered
through proteogenomics, the number of genes for which
proteomics data suggests a new start site, the number of validated
signal peptide cleavages, the total number of peptides discovered
in the MS/MS data for an organism.
(XLSX)
Table S2 Gene conflicts. This table presents the number of
conflicting loci, separated by type, for each genome.
(XLS)
Table S3 Change in conflicted loci according to PSM
specificity. For each organism, the number of conflicts (levels
4,5,6) are shown at two different PSM specificity cutoffs, a loose
5e-08 and the default 1e-10. With the loose cutoff there is often a
much larger number of conflicted loci, indicating a high false-
discovery at the protein level.
(XLS)
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